Testing a flexible-receptor docking algorithm in a model binding site

被引:140
作者
Wei, BQ
Weaver, LH
Ferrari, AM
Matthews, BW [1 ]
Shoichet, BK
机构
[1] Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
induced fit; molecular docking; conformational energy; X-ray crystallography; T4; lysozyme;
D O I
10.1016/j.jmb.2004.02.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sampling receptor flexibility is challenging for database docking. We consider a method that treats multiple flexible regions of the binding site independently, recombining them to generate different discrete conformations. This algorithm scales linearly rather than exponentially with the receptor's degrees of freedom. The method was first evaluated for its ability to identify known ligands of a hydrophobic cavity mutant of T4 lysozyme (L99A). Some 200,000 molecules of the Available Chemical Directory (ACD) were docked against an ensemble of cavity conformations. Surprisingly, the enrichment of known ligands from among a much larger number of decoys in the ACD was worse than simply docking to the apo conformation alone. Large decoys, accommodated in the larger cavity conformations sampled in the ensemble, were ranked better than known small ligands. The calculation was redone with an energy correction term that considered the cost of forming the larger cavity conformations. Enrichment improved, as did the balance between high-ranking large and small ligands. In a second retrospective test, the ACD was docked against a conformational ensemble of thymidylate synthase. Compared to docking against individual enzyme conformations, the flexible receptor docking approach improved enrichment of known ligands. Including a receptor conformational energy weighting term improved enrichment further. To test the method prospectively, the ACD database was docked against another cavity mutant of lysozyme (L99A/M102Q). A total of 18 new compounds predicted to bind this polar cavity and to change its conformation were tested experimentally; 14 were found to bind. The bound structures for seven ligands were determined by X-ray crystallography. The predicted geometries of these ligands all corresponded to the observed geometries to within 0.7 Angstrom RMSD or better. Significant conformational changes of the cavity were observed in all seven complexes. In five structures, part of the observed accommodations were correctly predicted; in two structures, the receptor conformational changes were unanticipated and thus never sampled. These results suggest that although sampling receptor flexibility can lead to novel ligands that would have been missed when docking a rigid structure, it is also important to consider receptor conformational energy. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1161 / 1182
页数:22
相关论文
共 63 条
[41]  
Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO
[42]  
2-4
[43]   A RAPID FINITE-DIFFERENCE ALGORITHM, UTILIZING SUCCESSIVE OVER-RELAXATION TO SOLVE THE POISSON-BOLTZMANN EQUATION [J].
NICHOLLS, A ;
HONIG, B .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1991, 12 (04) :435-445
[44]   Automated docking to multiple target structures:: Incorporation of protein mobility and structural water heterogeneity in AutoDock [J].
Österberg, F ;
Morris, GM ;
Sanner, MF ;
Olson, AJ ;
Goodsell, DS .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2002, 46 (01) :34-40
[45]   TERTIARY TEMPLATES FOR PROTEINS - USE OF PACKING CRITERIA IN THE ENUMERATION OF ALLOWED SEQUENCES FOR DIFFERENT STRUCTURAL CLASSES [J].
PONDER, JW ;
RICHARDS, FM .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 193 (04) :775-791
[46]   Structure-based discovery of a novel, noncovalent inhibitor of AmpC β-lactamase [J].
Powers, RA ;
Morandi, F ;
Shoichet, BK .
STRUCTURE, 2002, 10 (07) :1013-1023
[47]   Binding of the anticancer drug ZD1694 to E-coli thymidylate synthase: Assessing specificity and affinity [J].
Rutenber, EE ;
Stroud, RM .
STRUCTURE, 1996, 4 (11) :1317-1324
[48]  
Schapira Matthieu, 2001, BMC Structural Biology, V1, P1, DOI 10.1186/1472-6807-1-1
[49]   Virtual screening with solvation and ligand-induced complementarity [J].
Schnecke, V ;
Kuhn, LA .
PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 2000, 20 (01) :171-190
[50]  
Schnecke V, 1998, PROTEINS, V33, P74, DOI 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.3.CO